pre-IPO PHARMA

COMPANY OVERVIEW

None


LOCATION


THERAPEUTIC AREAS


WEBSITE

https://uniontherapeutics.com/


CAREER WEBSITE

None


SOCIAL MEDIA


INVESTORS


PRESS RELEASES


Jun 21, 2023

UNION therapeutics announces positive topline results from the OSIRIS investigator-initiated proof-of-concept study of oral orismilast in patients with hidradenitis suppurativa USA - English USA - English


May 10, 2023

UNION therapeutics to present at 4th Annual Dermatology Drug Development Summit Europe USA - English USA - English


Apr 21, 2023

UNION therapeutics to participate at Kempen Life Science Conference


Jan 10, 2023

UNION therapeutics receives FDA Fast Track designation for oral orismilast for the treatment of moderate to severe hidradenitis suppurativa USA - English USA - English


Jan 10, 2023

UNION therapeutics receives FDA Fast Track designation for oral orismilast for the treatment of moderate to severe hidradenitis suppurativa USA - English USA - English


For More Press Releases


Google Analytics Alternative